Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael K. Handley currently holds 24,265 shares of Cytocom, Inc. (CBLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael K. Handley has been a net neutral trader of CBLI stock. They have purchased $0 and sold $0 worth of shares.
Michael K. Handley's most recent insider trade was on May 18, 2026, when they sold 2,206 shares at $0.00 per share.
Michael K. Handley serves as Executive at Cytocom, Inc. (CBLI). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Michael K. Handley holds the position of Executive at Cytocom, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Michael K. Handley has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael K. Handley was on May 18, 2026, when they sold $0 worth of VBIO shares. This transaction involved 2,206 shares at N/A per share.
Michael K. Handley currently owns 24,265 shares of Cytocom, Inc. (CBLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael K. Handley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael K. Handley has 3 Form 4 filings on record as an insider at Cytocom, Inc..
Set alerts for Michael K. Handley and 40,000+ other insiders.